Anand Sampath, EVP, Operations & Clinical Research at MASIMO CORP (MASI), sold 19,796 shares at $180.00 ($3.6M) on 2020-04-13, disclosed to the SEC on 2020-04-15.
Open-market sale of $3.6M MASI by EVP, Operations & Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MASI | SELL | 2019-11-21 | $2.3M | — | Filing → |
| MASI | SELL | 2019-06-18 | $4.3M | — | Filing → |
| MASI | SELL | 2019-01-16 | $3.5M | — | Filing → |